A new paradigm for treating lung cancer by targeting the intratumoral microbiome.
0/5 보강
APA
Wei W (2026). A new paradigm for treating lung cancer by targeting the intratumoral microbiome.. Acta pharmaceutica Sinica. B, 16(2), 1168-1169. https://doi.org/10.1016/j.apsb.2026.01.011
MLA
Wei W. "A new paradigm for treating lung cancer by targeting the intratumoral microbiome.." Acta pharmaceutica Sinica. B, vol. 16, no. 2, 2026, pp. 1168-1169.
PMID
41685144
같은 제1저자의 인용 많은 논문 (5)
- Deciphering MFAP5+ Fibroblasts in Pancreatic Cancer Progression via Multi-Regional Single-Cell RNA Sequencing With Experimental Validation.
- polysaccharides inhibit castration-resistant prostate cancer progression possibly via dual modulation of PIK3R1 and PGC-1α: a preclinical evaluation.
- A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Patients with Cancer (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory.
- Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
- The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.